live In the news:
Boston Scientific to Acquire Axonics For About $3.7 Billion

Axonics

8 days ago
bookmarkBookmark

Axonics is a company. It is in Irvine, the United States and it has a male CEO called Raymond W. Cohen. It was founded in 2013 and is part of the Health Care sector, specifically in the Health Care Equipment & Supplies industry.

Key facts

plus See more facts


Extract data

Download datasets about Axonics:

dataset Dataset of stocks from Axonics:

Axonics is one of the companies in Health Care Equipment & Supplies, companies in Health Care, companies in Irvine, companies in the United States and 3,456,835 companies in our database.

Talking Points

  • Axonics® Therapy | Get Your Bladder Back
  • Axonics® System is an FDA-approved, clinically proven Sacral Neuromodulation solution for the treatment of urinary and bowel dysfunction.
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.

Related

Connected or similar to Axonics: .

This dashboard is based on data from: YAHOO-FIN, YFINANCE, Twitter.

This content is available under the CC BY 4.0 license.